Quality of Life and Decisional Regret in Patients Affected by Acoustic Neuroma

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 24, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how living with acoustic neuroma, a type of tumor that affects hearing, impacts patients' quality of life and their feelings about the decisions they've made regarding their treatment. The researchers are using two questionnaires to gather information about patients' experiences and feelings, specifically focusing on those who are either being monitored or have had surgery for their condition.

To participate in this study, you should be between the ages of 65 and 74 and have been diagnosed with a sporadic acoustic neuroma. However, individuals with certain conditions, such as neurofibromatosis type 2 (NF2), previous radiation treatment to the head and neck, or existing severe mental health issues are not eligible. If you join the trial, you will be asked to complete the questionnaires, which will help the researchers understand how acoustic neuroma affects patients' daily lives and decisions. This information may lead to better support and resources for those facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient with sporadic acoustic neuroma in follow-up with wait and scan protocol or treated with microsurgical resection with any approach
• Exclusion Criteria:
• • Patient with NF2
• • Patient previuosly treated with RT in the head and neck district
• • Patient with pre-treatment facial palsy ipsi and controlateral
• • Patient non native italian speakers
• • Patient with major mental illness already existing before the acoustic neuroma diagnosis
• • Patient with neurological issues such as chronic migraine or postural instability already existing before the acoustic neuroma diagnosis